How Microbial Fermentation And Protein Biomanufacturing Works

Luina Bio’s manufacturing facility offers the latest fermentation technologies supported by world-renowned expertise in drug development and production

Microbial fermentation is the basis for the production of a wide variety of pharmaceutical drugs and biologics, from anti-cancer drugs and vaccines to hormonal disorder therapies and many others.

Over the past 10 years, more half of the 150 recombinant pharmaceutical products approved for human use by the US Food and Drug Administration and The European Medicines Agency were manufactured via microbial fermentation using bacteria or yeast¹.

The global market for protein-based biologics derived from microbial fermentation, valued at US$44 billion in 2017, is projected to grow to US$60 billion by 2020, while the market for peptide hormones and vaccines is expected to increase from US$18 to US$28 billion and US$10 to US$19 billion, respectively, over the same period².